Smoking Cessation and Nicotine De-Addiction Products Market to Be Worth US $20.5 Bn by 2023
The increasing issues of high dependence on nicotine and subsequent health problems have led to the creation of many opportunities in the global market for products of smoking cessation and nicotine de-addiction. Some of the key players in the global smoking cessation and nicotine de-addiction products market include names such as Novartis, GlaxoSmithKline, Pfizer, GSK, Johnson & Johnson, VMR Products LLC, Lorillard Inc., NJOY, and Nicotek LLC. These players are making considerable investments in carrying out clinical experiments to examine...
View full press release